Kristin Rojas, MD
Surgical Oncology · Miami, FLNPI 1396185997
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $45,508 of the $56,967 with a category attached, or 79.9%. 19 manufacturers reported payments, led by Roche Molecular Systems, Inc. at 42.5% of the total. Reporting peaked in 2020 at $18,526 and has fallen 79.5% since, to $3,796 in 2025. Among surgical oncology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $703.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Molecular Systems, Inc.$24K
- Pacira Pharmaceuticals Incorporated$21K
- Tersera Therapeutics LLC$6K
- Merck$3K
- Novartis$2K
- Axogen$500
- plus $970 from 13 others
What the payments were for
- Consulting fees$45,50880%
- Speaking & faculty fees$5,0009%
- Travel & lodging$4,3778%
- Food & beverage$2,0834%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Molecular Systems, Inc. | 18 | $24,239 |
| Pacira Pharmaceuticals Incorporated | 21 | $20,687 |
| Tersera Therapeutics LLC | 13 | $5,652 |
| Merck | 7 | $3,043 |
| Novartis | 1 | $1,875 |
| Axogen | 1 | $500 |
| Endomagnetics Ltd | 3 | $240 |
| Davol Inc. | 1 | $168 |
| Hologic Sales And Service, LLC | 1 | $147 |
| Daiichi Sankyo Inc. | 5 | $115 |
| Hologic Inc | 1 | $114 |
| Stemline Therapeutics Inc. | 2 | $41 |
| Myriad Genetic Laboratories, Inc. | 1 | $27 |
| Gilead | 1 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Coopersurgical, Inc. | 1 | $14 |
| Boston Scientific | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$19,733
- DIAGNOSTICS INFORMATION SYSTEMS$14,400
- ZOLADEX$5,357
- Iovera$4,573
- Zilretta$3,753
- KISQALI$1,875
- AXOGUARD$1,000
- AXOGUARD HA+ NERVE PROTECTOR$500
- AxoGuard Nerve Cap$500
- Magseed$275
- Magtrace$275
- PHASIX$168
- SENTIMAG$147
- BioZorb$114
- Localizer$114
How this compares
$56,967 in reported general payments places this provider in the 90th percentile of 133 surgical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Miami
- Neha GoelMiami$200K
- Horacio AsbunMiami$161K
- Mehran HabibiMiami$73K
- Amit KhithaniMiami$32K
- Geoffrey YoungMiami$22K
- Nipun MerchantMiami$11K
- Meghan CrawleyMiami$5K
- Julie GrossmanMiami$4K
- Levan TsamalaidzeMiami$4K
- Ahkeel AllenMiami$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.